Third-generation cephalosporins

References

• Gleckman R, Gantz NM. The third-generation cephalosporins: a plea for restraint. (Editorial) Arch Intem Med 1982: 142(7): 1267–8
   PubMed Web of Science ®Google Scholar
• Thompson RL. Cephalosporin, carbapenem, and monobactam antibiotics. Mayo Clin Proc 1987: 62(9): 821–34 [Erratum, Mayo Clin Proc 1988: 63(1): 92]
   PubMed Web of Science ®Google Scholar
• Quenzer RW. A perspective of cephalosporins in pneumonia. Chest 1987: 92(3): 531–5
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. 1985 STD treatment guidelines. MMWR 1985: 34(Suppl 4): 75–108S
   PubMedGoogle Scholar
• Centers for Disease Control. Disseminated gonorrhea caused by peniclllinase-producing Neisseria gonorrhoeae—Wisconsin, Pennsylvania. MMWR 1987: 36(11): 161–2, 167
   PubMedGoogle Scholar
• Centers for Disease Control. Sentinel surveillance system for antimicrobial resistance in clinical isolates of Neisseria gonorrhoeae. MMWR 1987: 36(35): 585–6, 591–3
   PubMedGoogle Scholar
• Boslego JW, Tramont EC, Takafoji ET, et al. Effect of spectinomycin use on the prevalence of spec- tinomycin-resistant and of penicillinase-producing Nelsserlagonorrhoeae. NEngl JMed 1987: 317(5): 272–8
   PubMed Web of Science ®Google Scholar
• Judson FN. Treatment of uncomplicated gonorrhea with ceftriaxone: a review. Sex Transm Dis 1986: 13(3 Suppl): 199–202
   PubMed Web of Science ®Google Scholar
• Rice RJ, Thompson SE. Treatment of uncomplicated infections due to Neisseria gonorrhoeae: a review of clinical efficacy and in vitro susceptibility studies from 1982 through 1985. JAMA 1986: 255(13): 1739–46
   PubMed Web of Science ®Google Scholar
• Treatment of sexually transmitted diseases. Med Lett Drugs Ther 1986: 28(708): 23–8
   PubMed Web of Science ®Google Scholar
• Fiumara NJ. Update on the treatment of sexually transmitted diseases. Compr Ther 1986: 12(4): 38–43
   PubMedGoogle Scholar
• Judson FN, Ehret JM, Handsfield HH. Comparative study of ceftriaxone and spectinomycin for treatment of pharyngeal and anorectal gonorrhea. JAMA 1985: 253(10): 1417–9
   PubMed Web of Science ®Google Scholar
• Schmid GP, Sanders LL Jr, Blount JH, et al. Chancroid in the United State?: reestablishment of an old disease. JAMA 1987: 258(22): 3265–8
   PubMed Web of Science ®Google Scholar
• Schmid GP. The treatment of chancroid. JAMA 1986: 255(13): 1757–62
   PubMed Web of Science ®Google Scholar
• Taylor DN, Pitarangsi C, Echeverria P, et al. Comparative study of ceftriaxone and trlmethoprim- sulfamethoxazolefor the treatment of chancroid in Thalland. J Infect Dis 1985: 152(5): 1002–6
   PubMed Web of Science ®Google Scholar
• Bowmer MI, Nsanze H, D'Costa LJ, et al. Singledose ceftriaxone for chancroid. Antimicrob Agents Chemother 1987: 31 (1): 67–9
   PubMed Web of Science ®Google Scholar
• Johnson RG, Bey RF, Wolgamot SJ. Comparison of the activities of ceftriaxone and penicillin G against experimentally induced syphilis in rabbits. Antimicrob Agents Chemother 1982: 21(6): 984–9
   PubMed Web of Science ®Google Scholar
• Hook EW 3d, Baker-Zander SA, Moskovltz BL, et al. Ceftriaxone therapy for asymptomatic neurosyphilis: case report and Western blot analysis of serum and cerebrospinal fluid IgG response to therapy. Sex Transm Dis 1986: 13(3 Suppl): 185–8
   PubMed Web of Science ®Google Scholar
• Hook EW 3d, Roddy RE, Handsfield HH. Ceftriaxone therapy for incubating and early syphilis. J Infect Dis 1988: 158(10): 881–4
   PubMed Web of Science ®Google Scholar
• Cherubin CE. Antibiotic resistance of Salmonella in Europe and the United States. Rev Infect Dis 1981: 3(6): 1105–26
   PubMedGoogle Scholar
• Bryan JP, Rocha H, Scheid WM. Problems in salmonellosis: rationale for clinical trials with newer beta-lactam agents and quinolones. Rev Infect Dis 1986: 8(2): 189–207
   PubMedGoogle Scholar
• Soe GB, Oyerturf GD. Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins. Rev Infect Dis 1987: 9(4): 719–36
   PubMedGoogle Scholar
• Smith SM, Pal umbo PE, Edelson PJ. Salmonella strains resistant to multiple antibiotics: therapeutic implications. Pediatr Infect Dis 1984: 3(5): 455–60
   PubMedGoogle Scholar
• MacDonald KL, Cohen ML, Hargrett-Bean NT. et al. Changes in antimicrobial resistance of Salmonella isolated from humans In the United States. JAMA 1987: 258(11): 1496–9
   PubMed Web of Science ®Google Scholar
• Dolan SA, Everett ED, Harper MC. Salmonella vertebral osteomyelitis treated with cefotaxime. Arch Intern Med 1987: 147(9): 1667–8
   PubMedGoogle Scholar
• Celum CL, Chaisson RE, Rutherford GW. et al. Incidence of salmonellosis in patients with AIDS. J Infect Dis 1987: 156(6): 998–1002
   PubMed Web of Science ®Google Scholar
• Jacobs JL, Gold JW, Murray HW, et al. Salmonella infections in patients with the acquired immunodeficiency syndrome. Ann Intem Med 1985: 102(2): 186–8
   PubMed Web of Science ®Google Scholar
• Rolston KV, Rodriguez S. Mansell PW. Antimicrobial therapy for Salmonella infections in the acquired immunodeficiency syndrome (AIDS). (Letter) Ann Intern Med 1988: 108(2): 309
   PubMed Web of Science ®Google Scholar
• Fischl MA. Dickinson GM. Sinave C. et al. Salmonella bacteremia as manifestation of acquired immunodeficiency syndrome. Arch Intern Med 1986: 146(1): 113–5
   PubMedGoogle Scholar
• Steere AC, Bartenhagen NH, Craft JE, etal. The early clinical manifestations of Lyme disease. Ann Intem Med 1983: 99(1): 76–82
   PubMed Web of Science ®Google Scholar
• Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med 1983: 99(1): 22–6
   PubMed Web of Science ®Google Scholar
• Steere AC, Green J, Schoen RT, et al. Successful parenteral penicillin therapy of established Lyme arthritis. N Engl J Med 1985: 312(14): 869–74
   PubMed Web of Science ®Google Scholar
• Dattwyler RJ, Halperin JJ, Pass H, et al. Ceftriaxone as effective therapy in refractory Lyme disease. J Infect Dis 1987: 155(6): 1322–5
   PubMed Web of Science ®Google Scholar
• Dattwyler RJ, Halperin JJ, Volkman DJ. et al. Treatment of late Lyme borreliosis—randomised comparison of ceftriaxone and penicillin. Lancet 1988: 1(8596): 1191–4
   PubMed Web of Science ®Google Scholar
• Pizzo PA, Thaler M, Hathorn J, et al. New betalactam antibiotics in granulocytopenic patients: new options and new questions. Am J Med 1985: 79(2A): 75–82
   PubMed Web of Science ®Google Scholar
• Schlmpff SC. Empiric antibiotic therapy for granulocytopenic cancer patients. Am J Med 1986: 80(5C): 13–20
   Web of Science ®Google Scholar
• The EORTC International Antimicrobial Therapy Cooperative Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 1987: 317(27): 1692–8
   PubMed Web of Science ®Google Scholar
• Bodey GP. Antibiotics in patients with neutropenia. Arch Intern Med 1984: 144(9): 1845–51
   PubMedGoogle Scholar
• Fainstein V, Bodey GP. Single-agent therapy for Infections in neutropenic cancer patients. Am J Med 1985: 79(2A): 83–8
   PubMed Web of Science ®Google Scholar
• Thornsberry C. Review of in vitro activity of third- generation cephalosporins and other newer beta- lactam antibiotics against clinically important bacteria. Am J Med 1985: 79(2A): 14–20
   PubMed Web of Science ®Google Scholar
• Gutmann L, Williamson R, Kitzis MD, et al. Synergism and antagonism in double beta-lactam antibiotic combinations. Am J Med 1986: 80(5C): 21–9
   PubMed Web of Science ®Google Scholar
• Pizzo PA, Hathorn JW, Hiemenz J, et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986: 315(9): 552–8
   PubMed Web of Science ®Google Scholar
• Hathorn JW, Rubin M, Pizzo PA. Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and Impact of monotherapy Antimicrob Agents Chemother 1987: 31(7): 971–7
   PubMed Web of Science ®Google Scholar
• Verhagen CS, de Pauw B, de Witte T, et al. Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients. Antimicrob Agents Chemother 1987: 31(2): 191–6
   PubMed Web of Science ®Google Scholar
• Rubin M, Hathorn JW, Marshall D, et al. Grampositive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med 1988: 108(1): 30–5
   PubMed Web of Science ®Google Scholar